Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;9(2):97-103.
doi: 10.2174/1574891x10666150326114221.

Current status of chemically synthesized inhibitors of Ebola virus

Anthony P Cardile  1 , Douglas L Mayers, Sina Bavari
Affiliations
Review

Current status of chemically synthesized inhibitors of Ebola virus

Anthony P Cardile et al. Recent Pat Antiinfect Drug Discov. 2014.

Abstract

The current Ebola virus outbreak is unprecedented in its scope and international impact. Given that there are currently no approved antivirals to treat Ebola virus, there is urgency to conduct more rapid development and evaluation of Ebola antivirals. Recently, the World Health Organization identified a number of antivirals as high priority to include AVI-6002 (AVI-7537 and AVI-7539), BCX4430, brincidofovir, favipiravir, and TKM-100802. This review describes these chemically synthesized inhibitors of Ebola virus, relevant patent development and gives an update on their current status.

PubMed Disclaimer

Similar articles

  • Will There Be a Cure for Ebola?
    Cardile AP, Warren TK, Martins KA, Reisler RB, Bavari S. Cardile AP, et al. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:329-348. doi: 10.1146/annurev-pharmtox-010716-105055. Epub 2016 Dec 7. Annu Rev Pharmacol Toxicol. 2017. PMID: 27959624 Review.
  • Infectious diseases. Ebola drug trials lurch ahead.
    Kupferschmidt K, Cohen J. Kupferschmidt K, et al. Science. 2015 Feb 13;347(6223):701-2. doi: 10.1126/science.347.6223.701. Science. 2015. PMID: 25678637 No abstract available.
  • Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.
    Madelain V, Nguyen TH, Olivo A, de Lamballerie X, Guedj J, Taburet AM, Mentré F. Madelain V, et al. Clin Pharmacokinet. 2016 Aug;55(8):907-23. doi: 10.1007/s40262-015-0364-1. Clin Pharmacokinet. 2016. PMID: 26798032 Free PMC article. Review.
  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Réné Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fiz… See abstract for full author list ➔ Sissoko D, et al. PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar. PLoS Med. 2016. PMID: 26930627 Free PMC article. Clinical Trial.
  • Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.
    Zhang T, Zhai M, Ji J, Zhang J, Tian Y, Liu X. Zhang T, et al. Bioorg Med Chem Lett. 2017 Jun 1;27(11):2364-2368. doi: 10.1016/j.bmcl.2017.04.028. Epub 2017 Apr 12. Bioorg Med Chem Lett. 2017. PMID: 28462833
See all similar articles

Cited by

LinkOut - more resources